Investment
Features
FeesSafety
Academy
More
Pluang+

Compare VanEck Uranium & Nuclear ETF (NLR) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance

VanEck Uranium & Nuclear ETFTrade
Royalty Pharma plc Class A Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

VanEck Uranium & Nuclear ETF vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? VanEck Uranium & Nuclear ETF trades at $103.53 (market cap $3.51B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.88 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 7.2× VanEck Uranium & Nuclear ETF's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while VanEck Uranium & Nuclear ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold VanEck Uranium & Nuclear ETF for 8 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.

NLRRPRX
Market Cap
$3.51B$25.27B
Volume
414,5163,671,183
Sector
Sector/ThematicHealth
52-Week High
$164.37$63.96
52-Week Low
$102.38$35.44
Typical Hold Time
8 Days1 Days
Enterprise Value
—$32.50B
Dividend Yield
—1.66%

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NLR
0% Buy100% Sell
Avg holding period · 8 Days
RPRX

No sentiment data available yet.

Top news

Latest headlines on both assets

About VanEck Uranium & Nuclear ETF

VanEck Uranium and Nuclear ETF seeks exposure to companies involved in uranium mining and the nuclear power industry. Its holdings may include miners, utilities, reactor-related companies, and nuclear equipment or service providers.

Read more on NLR →

About Royalty Pharma plc Class A Ordinary Shares

Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.

Read more on RPRX →